Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 30.49-6.23-32.1036.7145.25

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is 30.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202530.49
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 30.49
Positive
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹169,231.0 Cr -2.3% -3.3% 12.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,034.0 Cr 0.9% 5.3% 1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,875.0 Cr -3.3% 2.8% 19.7% Stock Analytics
CIPLA ₹122,082.0 Cr -1.6% -9.2% 4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,873.0 Cr NA -3.5% 4.6% Stock Analytics
MANKIND PHARMA ₹92,581.7 Cr -0.1% -8.3% -14% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-2.3%

-3.3%

12.2%

SENSEX

0.8%

1%

9.9%


You may also like the below Video Courses